The billions of mRNA vaccine doses that went into arms worldwide during the COVID-19 pandemic build on clinical trial data confirming the safety and effectiveness of a vaccine technology now poised to personalize cancer treatment, according to a new review. Dr. Manish Sadarangani, director of the Vaccine Evaluation Centre at B.C. Children's Hospital, and his co-authors combed through published data from laboratory research, clinical trials and real-world surveillance from Pfizer-BioNTech’s and Moderna’s mRNA vaccines from January 2020 through December 2025 to assess their scientific and public health impacts. In Tuesday's issue of the medical journal The Lancet, the researchers highlighted...